Professor Xiao-Ning Xu talks about his research on emerging infectious diseases in China, from the SARS outbreak in 2003/4 to flu pandemic and HIV infection.
Professor Xu also follows a HIV cohort in Beijing, and studies their T cell responses to the HIV conserved region. The stimulation of HIV-specific cytolytic T lymphocytes offers a new strategy for vaccine development.
